Clinical Trial Update: Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO) Phase I

View source ↗

Summary

This entry describes a Phase I clinical trial (MAMBO) evaluating molecular and clinical biomarkers for migraine attack treatment response, which is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Migraine Disorders | Status: RECRUITING